{
    "persona": "conservative",
    "model": "llama2:70b-chat-q6_K",
    "topic": "healthcare",
    "language": "Dutch",
    "text": "70% van patiënten met atogepant 60 mg dagelijks hadden minstens 50% vermindering van maandelijke migrainedagen na 13-16 weken en dit werd géén 48 weken behouden.",
    "retrieved_source": "https://www.medscape.com/viewarticle/first-long-term-data-atogepant-migraine-prevention-2024a10007cb",
    "annotation": {
        "topic": null,
        "persona": null,
        "authenticity": null
    },
    "id": "469b1c168c18d25ac9e962aedf974aebd763cc5f97084d4c"
}